Key Details
Price
$13.10PE Ratio
0.11Annual ROE
-475.31%Beta
1.38Events Calendar
Next earnings date:
N/ARecent quarterly earnings:
Feb 28, 2025Recent annual earnings:
Feb 28, 2025Next ex-dividend date:
N/ARecent ex-dividend date:
N/ANext split:
N/ARecent split:
N/AAnalyst ratings
Recent major analysts updates
Jan 22, 25 JMP Securities
Market PerformJul 23, 24 JMP Securities
Market PerformJan 23, 24 JMP Securities
Market PerformNov 20, 23 JMP Securities
Market OutperformAug 23, 23 JMP Securities
OutperformMay 10, 23 JMP Securities
Market OutperformMar 8, 23 JMP Securities
Market OutperformMar 7, 23 Credit Suisse
OutperformNov 8, 22 Credit Suisse
OutperformOct 5, 22 Evercore ISI Group
OutperformMarket Data
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Price
Market cap
Technical
Dividend
Inhibrx Biosciences doesn't have historical dividend data
Profitability
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Revenue
Profit
EPS
ROA & ROE
EBIT & EBITDA
Valuation
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
PE Ratio
PB Ratio
PS Ratio
Enterprise value
EV/EBITDA
Financial Health
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Liquidity
Leverage
Risk & Stability
Balance Sheet
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Assets
Equity
Liabilities
Debt
Expenses
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Cash Flow
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Cashflow Activities
Free CashFlow
CAPEX
Institutional Ownership
FAQ
- What is the ticker symbol for Inhibrx Biosciences?
- Does Inhibrx Biosciences pay dividends?
- What sector is Inhibrx Biosciences in?
- What industry is Inhibrx Biosciences in?
- What country is Inhibrx Biosciences based in?
- When did Inhibrx Biosciences go public?
- Is Inhibrx Biosciences in the S&P 500?
- Is Inhibrx Biosciences in the NASDAQ 100?
- Is Inhibrx Biosciences in the Dow Jones?
- When was Inhibrx Biosciences's last earnings report?
- When does Inhibrx Biosciences report earnings?
- Should I buy Inhibrx Biosciences stock now?
What is the ticker symbol for Inhibrx Biosciences?
The ticker symbol for Inhibrx Biosciences is NASDAQ:INBX
Does Inhibrx Biosciences pay dividends?
No, Inhibrx Biosciences does not pay dividends
What sector is Inhibrx Biosciences in?
Inhibrx Biosciences is in the Healthcare sector
What industry is Inhibrx Biosciences in?
Inhibrx Biosciences is in the Biotechnology industry
What country is Inhibrx Biosciences based in?
Inhibrx Biosciences is headquartered in United States
When did Inhibrx Biosciences go public?
Inhibrx Biosciences's initial public offering (IPO) was on June 4, 2024
Is Inhibrx Biosciences in the S&P 500?
No, Inhibrx Biosciences is not included in the S&P 500 index
Is Inhibrx Biosciences in the NASDAQ 100?
No, Inhibrx Biosciences is not included in the NASDAQ 100 index
Is Inhibrx Biosciences in the Dow Jones?
No, Inhibrx Biosciences is not included in the Dow Jones index
When was Inhibrx Biosciences's last earnings report?
Inhibrx Biosciences's most recent earnings report was on Feb 28, 2025
When does Inhibrx Biosciences report earnings?
The date for Inhibrx Biosciences's next earnings report has not been announced yet
Should I buy Inhibrx Biosciences stock now?
As of today, analysts generally recommend a 'Hold' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions